• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨大囊性嗜铬细胞瘤/副神经节瘤患者的误诊及临床特征分析

Misdiagnosis and analysis of clinical characteristics in patients with giant cystic pheochromocytoma/paraganglioma.

作者信息

Zhang Yue, Zhou Bo

机构信息

Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Department of Geriatrics, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.

出版信息

Discov Oncol. 2024 Dec 30;15(1):846. doi: 10.1007/s12672-024-01730-6.

DOI:10.1007/s12672-024-01730-6
PMID:39739206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11685362/
Abstract

INTRODUCTION

Although giant cystic pheochromocytoma and paraganglioma (PPGL) are uncommon, they can be life-threatening when it occurs. Unfortunately, prior case reports have shown that giant cystic PPGLs are highly susceptible to diagnostic errors. Therefore, this study aimed to explore giant cystic PPGLs by comparing them with non-cystic PPGLs, defining the clinical features of the affected patients, and analyzing the characteristics of misdiagnosis and mistreatment associated with PPGLs. The goal is to provide insights for the timely and accurate diagnosis and treatment of giant cystic PPGLs.

METHODS

A total of 170 cases of pheochromocytoma and paraganglioma (PPGL) diagnosed at the First Affiliated Hospital of Chongqing Medical University from April 2011 to April 2020 were confirmed through clinical evaluation, measurement of catecholamine metabolites, imaging studies, or surgical pathology. The patients were classified into two groups based on the maximum tumor diameter and the presence of cystic components. The clinical characteristics of patients in the giant cystic group, including timely diagnosis and instances of misdiagnosis, are summarized. Additionally, the differences in demographics, clinical manifestations, laboratory examinations, imaging features, treatment approaches, and tumor characteristics between the two groups were analyzed.

RESULTS

Among the 17 patients in the giant cystic group, eight (47.1%) patients were misdiagnosed. The misdiagnosis and mistreatment characteristics of PPGLs were as follows: female (50%); median age, 51 years; normal blood pressure; greater mass effect at onset; larger tumors; median time to diagnosis extension, 180 days; and misdiagnosed disease, which was mainly tumors of adjacent organs, the digestive system, the cardiovascular system, the urinary system, the nervous system, or the endocrine system. The giant cystic group had greater mass effects than did the non-cystic group (P < 0.05). The proportion of patients with the triad of pheochromocytoma (heart palpitations, sweating and headache) and hypertension was lower; however, this difference was not statistically significant. The blood MN (metanephrine) level was greater, and the hemoglobin and blood low-density lipoprotein cholesterol (LDL-cholesterol) levels were lower (P < 0.05). The proportions of patients with tumor calcification and hemorrhagic necrosis were significantly greater (P < 0.05). There was more intraoperative bleeding, more patients who underwent blood transfusions, and a longer postoperative hospital stay; however, the difference was not statistically significant.

CONCLUSION

Giant cystic pheochromocytomas and paragangliomas (PPGLs) are rare, and their clinical manifestations are atypical. Additionally, imaging findings can be challenging to identify due to the presence of large space-occupying adjacent organs. As a result, these giant cystic lesions of unknown origin are often misdiagnosed. Early biochemical examination, in conjunction with imaging characteristics, is essential to accurately determine the nature of the tumor and reduce the rate of misdiagnosis.

摘要

引言

尽管巨大囊性嗜铬细胞瘤和副神经节瘤(PPGL)并不常见,但一旦发生可能危及生命。不幸的是,既往病例报告显示巨大囊性PPGL极易出现诊断错误。因此,本研究旨在通过将巨大囊性PPGL与非囊性PPGL进行比较,明确受累患者的临床特征,并分析与PPGL相关的误诊和误治特点,以探索巨大囊性PPGL。目的是为巨大囊性PPGL的及时准确诊断和治疗提供见解。

方法

对2011年4月至2020年4月在重庆医科大学附属第一医院确诊的170例嗜铬细胞瘤和副神经节瘤(PPGL)患者,通过临床评估、儿茶酚胺代谢产物测定、影像学检查或手术病理进行确诊。根据肿瘤最大直径和是否存在囊性成分将患者分为两组。总结巨大囊性组患者的临床特征,包括及时诊断和误诊情况。此外,分析两组在人口统计学、临床表现、实验室检查、影像学特征、治疗方法和肿瘤特征方面的差异。

结果

巨大囊性组的17例患者中,8例(47.1%)被误诊。PPGL的误诊和误治特征如下:女性(50%);中位年龄51岁;血压正常;起病时占位效应更大;肿瘤更大;诊断延迟的中位时间为180天;误诊疾病主要为相邻器官、消化系统、心血管系统、泌尿系统、神经系统或内分泌系统的肿瘤。巨大囊性组的占位效应比非囊性组更大(P<0.05)。嗜铬细胞瘤三联征(心悸、出汗和头痛)和高血压患者的比例较低;然而,这种差异无统计学意义。血MN(甲氧基肾上腺素)水平更高,血红蛋白和血低密度脂蛋白胆固醇(LDL-胆固醇)水平更低(P<0.05)。肿瘤钙化和出血坏死患者的比例显著更高(P<0.05)。术中出血更多,接受输血的患者更多,术后住院时间更长;然而,差异无统计学意义。

结论

巨大囊性嗜铬细胞瘤和副神经节瘤(PPGL)罕见,其临床表现不典型。此外,由于存在占据较大空间的相邻器官,影像学表现难以识别。因此,这些不明来源的巨大囊性病变常被误诊。早期生化检查结合影像学特征对于准确判断肿瘤性质和降低误诊率至关重要。

相似文献

1
Misdiagnosis and analysis of clinical characteristics in patients with giant cystic pheochromocytoma/paraganglioma.巨大囊性嗜铬细胞瘤/副神经节瘤患者的误诊及临床特征分析
Discov Oncol. 2024 Dec 30;15(1):846. doi: 10.1007/s12672-024-01730-6.
2
[Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].血浆游离甲氧基肾上腺素正常的嗜铬细胞瘤和副神经节瘤的临床特征
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):614-620. doi: 10.19723/j.issn.1671-167X.2020.04.003.
3
Pheochromocytoma and Paraganglioma: From Clinical Findings to Diagnosis.嗜铬细胞瘤和副神经节瘤:从临床发现到诊断
Sisli Etfal Hastan Tip Bul. 2020 Sep 8;54(3):271-280. doi: 10.14744/SEMB.2020.14826. eCollection 2020.
4
Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.嗜铬细胞瘤和副神经节瘤:基于临床特征的疾病可能性与儿茶酚胺生化的关系及疾病怀疑的原因。
Eur J Endocrinol. 2019 Oct;181(4):409-420. doi: 10.1530/EJE-19-0159.
5
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.嗜铬细胞瘤和副神经节瘤的诊断:韩国嗜铬细胞瘤和副神经节瘤工作组的联合立场声明。
Endocrinol Metab (Seoul). 2021 Apr;36(2):322-338. doi: 10.3803/EnM.2020.908. Epub 2021 Apr 6.
6
Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.手术切除的嗜铬细胞瘤和副神经节瘤患者的临床特征。
Korean J Intern Med. 2020 Mar;35(2):351-359. doi: 10.3904/kjim.2018.231. Epub 2019 Feb 28.
7
Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.小儿转移性嗜铬细胞瘤和副神经节瘤:临床表现和诊断、遗传学和治疗方法。
Front Endocrinol (Lausanne). 2022 Jul 12;13:936178. doi: 10.3389/fendo.2022.936178. eCollection 2022.
8
Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients.术后诊断为嗜铬细胞瘤和交感神经副神经节瘤患者术中血流动力学不稳定的特征。
Front Endocrinol (Lausanne). 2022 Feb 24;13:816833. doi: 10.3389/fendo.2022.816833. eCollection 2022.
9
Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.半定量¹²³I-间碘苄胍闪烁扫描术鉴别嗜铬细胞瘤和副神经节瘤与生理性肾上腺摄取及其与儿茶酚胺转运体基因型依赖性表达的相关性
J Nucl Med. 2015 Jun;56(6):839-46. doi: 10.2967/jnumed.115.154815. Epub 2015 Apr 16.
10
Prognostic value of [F]FDG-PET prior to [I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL).[F]FDG-PET在[I]MIBG治疗嗜铬细胞瘤和副神经节瘤(PPGL)之前的预后价值。
Ann Nucl Med. 2023 Jan;37(1):10-17. doi: 10.1007/s12149-022-01798-6. Epub 2022 Oct 27.

本文引用的文献

1
Comparison of robot-assisted retroperitoneal laparoscopic adrenalectomy versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: a single-centre retrospective study.机器人辅助腹膜后腹腔镜肾上腺切除术与腹膜后腹腔镜肾上腺切除术治疗大嗜铬细胞瘤的比较:一项单中心回顾性研究
BMC Surg. 2020 Oct 7;20(1):227. doi: 10.1186/s12893-020-00895-5.
2
Complete atrioventricular dissociation and sinus arrest after pheochromocytoma resection.嗜铬细胞瘤切除术后出现完全性房室分离和窦性停搏。
IJU Case Rep. 2020 Apr 18;3(3):108-111. doi: 10.1002/iju5.12160. eCollection 2020 May.
3
Pheochromocytoma.嗜铬细胞瘤
Endocr Regul. 2019 Jul 1;53(3):191-212. doi: 10.2478/enr-2019-0020.
4
PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.嗜铬细胞瘤:遗传学和诊断学更新。
Endocr Pract. 2018 Jan;24(1):78-90. doi: 10.4158/EP-2017-0057. Epub 2017 Nov 16.
5
Cystic adrenal lesions: focus on pediatric population (a review).肾上腺囊性病变:聚焦儿科人群(综述)
Clujul Med. 2017;90(1):5-12. doi: 10.15386/cjmed-677. Epub 2017 Jan 15.
6
Adrenal incidentalomas: a disease of modern technology offering opportunities for improved patient care.肾上腺偶发瘤:一种现代技术带来的疾病,为改善患者护理提供了机遇。
Endocrinol Metab Clin North Am. 2015 Jun;44(2):335-54. doi: 10.1016/j.ecl.2015.02.005.
7
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.嗜铬细胞瘤和副神经节瘤:内分泌学会临床实践指南
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42. doi: 10.1210/jc.2014-1498.
8
Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors.53 例经组织学证实的肿瘤患者伴发临床和生化特征的嗜铬细胞瘤的多模态影像学表现。
AJR Am J Roentgenol. 2013 Oct;201(4):825-33. doi: 10.2214/AJR.12.9576.
9
Risk factors affecting operative approach, conversion, and morbidity for adrenalectomy: a single-institution series of 402 patients.影响肾上腺切除术手术入路、中转和发病率的风险因素:单机构 402 例系列研究。
Surg Endosc. 2013 Jul;27(7):2342-50. doi: 10.1007/s00464-013-2789-7. Epub 2013 Feb 13.
10
Pheochromocytoma crisis is not a surgical emergency.嗜铬细胞瘤危象不是手术急症。
J Clin Endocrinol Metab. 2013 Feb;98(2):581-91. doi: 10.1210/jc.2012-3020. Epub 2013 Jan 2.